The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia

被引:41
|
作者
Choi, KH
Lee, HB
Jeong, MY
Rhee, YK
Chung, MJ
Kwak, YG
Lee, YC
机构
[1] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Internal Med, Chonju 561712, Chonbuk, South Korea
[2] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Pathol, Chonju 561712, Chonbuk, South Korea
[3] Chonbuk Natl Univ Med Sch, Res Inst Clin Med, Dept Pharmacol, Chonju 561712, Chonbuk, South Korea
关键词
cryptogenic organizing pneumonia; lymphocyte; matrix metalloproteinase-9; neutrophil; tissue inhibitor of metalloproteinase-1; usual interstitial pneumonia;
D O I
10.1378/chest.121.5.1478
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The processes observed in interstitial lung disease are associated with the production, deposition, and proteolysis of the extracellular matrix (ECM), which may lead to irreversible pulmonary structural remodeling or to appropriate repair without fibrosis. Matrix metalloproteinases (MMPs) and a tissue inhibitor of metalloproteinases (TIMPs) are known to regulate remodeling of the ECM and thus to be important in the process of lung fibrosis. Pulmonary structures are extensively remodeled in usual interstitial pneumonia (UIP), whereas severe architectural remodeling is minimally present in cryptogenic organizing pneumonia (COP). However, not much is known about the roles of MMP-9 and/or TIMP-1 in COP. Methods: Levels of MMP-9, TIMP-1 and the molar ratio of MMP-9/TIMP-1 in BAL fluids were investigated in 11 patients with UIP, in 8 patients with COP, and in 10 control subjects. We checked the levels of MMP-9 and TIMP-1 by means of enzyme immunoassay, and the hydrolytic activity of MMP-9 in BAL fluids was measured by gelatin zymography. Further, we evaluated the expression of MMP-9 and TIMP-1 in lung tissue by immunohistochemistry. Results: The concentrations of MMP-9 and TIMP-1 were significantly increased in patients with UIP and were even higher in patients with COP compared with control subjects. The levels of MMP-9 and TIMP-1 were significantly higher in patients with COP than in patients with UIP. The molar ratio of MMP-9/TIMP-1 was significantly higher in patients with COP than in control subjects. In patients with COP, the concentration of MMP-9 significantly correlated with the number of neutrophils and lymphocytes. Zymographic analysis revealed that the activity of the 92-kd pro-MMP-9 was increased in patients with UIP and was even higher in patients with COP, compared with control subjects. Conclusions: These data suggest that overproduction of MMP-9 and TIMP-1, and an imbalance between MMP-9 and TIMP-1, may have a role as diagnostic references in COP.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [1] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis
    Szamatowicz, J
    Laudanski, P
    Tomaszewska, I
    [J]. HUMAN REPRODUCTION, 2002, 17 (02) : 284 - 288
  • [2] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    [J]. BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [3] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [4] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [5] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618
  • [6] Role of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and hyaluronic acid in acute pyelonephritis
    Kavaz, A.
    Ekim, M.
    Ikinciogullari, A.
    Guloglu, D.
    Ozcakar, Z. B.
    Yalcinkaya, F.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1701 - 1701
  • [7] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [8] The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the growth type of cholangiocarcinoma.
    Park, YN
    Chae, KJ
    Koo, JS
    Oh, BK
    Rha, SY
    Yang, WI
    Choi, JS
    [J]. HEPATOLOGY, 2002, 36 (04) : 397A - 397A
  • [9] Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
    Madjid, Tita Husnitawati
    Ardiansyah, Dennis Fachmi
    Permadi, Wiryawan
    Hernowo, Bethy
    [J]. DIAGNOSTICS, 2020, 10 (06)
  • [10] Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma
    Tanaka, H
    Miyazaki, N
    Oashi, K
    Tanaka, S
    Ohmichi, M
    Abe, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 900 - 905